The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer
- 1 October 1974
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 9 (4), 285-315
- https://doi.org/10.1016/0009-2797(74)90019-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The orthomolecular treatment of cancer I. The role of ascorbic acid in host resistanceChemico-Biological Interactions, 1974
- URINARY OXALATE AND VITAMIN-C SUPPLEMENTSThe Lancet, 1973
- Ascorbic Acid and the GlycosaminoglycansOncology, 1973
- TREATMENT OF BREAST CANCERThe Lancet, 1972
- THE NEED FOR HUMANISED SCIENCE IN EVALUATING MEDICATIONThe Lancet, 1972
- ASCORBIC ACID, CELL PROLIFERATION, AND CANCERThe Lancet, 1972
- The Role of Ascorbic Acid in the Prevention of Bladder Tumor FormationJournal of Urology, 1970
- Seromucoid in the Diagnosis of CancerScottish Medical Journal, 1961